{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:45:15Z","timestamp":1790095515770,"version":"4.0.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","funder":[{"name":"NIH","award":["T32CA009216"],"award-info":[{"award-number":["T32CA009216"]}]},{"name":"NIH","award":["R01GM129783"],"award-info":[{"award-number":["R01GM129783"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Trimethoprim-sulfamethoxazole (TMP-SMX)-associated severe acute respiratory distress syndrome (ARDS) has gone underrecognized. We propose the first disease definition and clinical evaluation for a novel adverse drug reaction (ADR) based on a series of recently identified rare cases of life-threatening ADRs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>A retrospective study was conducted. All medical records were evaluated. Available pathology samples were sent to Massachusetts General for clinical consultation. Blood samples from surviving patients were obtained and human leukocyte antigen (HLA) analysis was performed by the Children\u2019s Mercy Hospital Genomic Center and Vanderbilt University Medical Center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>U.S. ICUs, 1996\u20132021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>Nineteen young patients (10\u201337) were identified. Patients were previously healthy, with no preexisting pulmonary disease, no other cause for respiratory failure, and no chronic history of smoking\/vaping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>\n                      Through our retrospective analysis, we analyzed clinical characteristics associated with TMP-SMX. Pathology samples were reviewed, and HLA analysis was performed on available samples by the study team or as standard of care at treatment hospitals in some cases. In 19 critically ill patients, we identified a pattern of severe respiratory failure requiring ICU admission, mechanical ventilation, and frequent extracorporeal membrane oxygenation use. We describe the first three-part clinical diagnosis and evaluation strategy: 1) Clinical definition: Unexplained severe respiratory failure in a patient receiving greater than or equal to 6 days of TMP-SMX at treatment dose (not prophylaxis). TMP-SMX ARDS is a diagnosis of exclusion. 2) Genetic association: One hundred percent of currently available TMP-SMX respiratory failure patient genomic data, (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 11) have been carriers of both\n                      <jats:italic toggle=\"yes\">HLA-B*07:02<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">HLA-C*07:02<\/jats:italic>\n                      alleles. HLA allele evaluation could be considered in patients with suspected TMP-SMX respiratory failure. 3) Lung pathology: A unique pulmonary pathologic pattern of lung injury termed diffuse alveolar injury with delayed epithelialization has been observed in these cases. In suspected cases, surgical lung biopsy early in the clinical course could be considered.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>TMP-SMX is a commonly prescribed antibiotic. However, we find it imperative to share this relatively rare but life-threatening condition with clinicians as the mortality rate approaches 40%.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006002","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:37:33Z","timestamp":1689331053000},"page":"e264-e268","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Definition and Clinical Evaluation for Trimethoprim-Sulfamethoxazole Severe Acute Respiratory Failure"],"prefix":"10.1097","volume":"51","author":[{"given":"Jenna","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Mercy Hospital, University of Missouri\u2013Kansas City, Kansas City, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hason","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Mercy Hospital, University of Missouri\u2013Kansas City, Kansas City, MO."},{"name":"Kansas City University of Medicine and Biosciences, Kansas City, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Mino-Kenudson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Shih","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Goldman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Mercy Hospital, University of Missouri\u2013Kansas City, Kansas City, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"R2-20250502","first-page":"181","article-title":"Interstitial lung disease during trimethoprim\/sulfamethoxazole administration.","volume":"64","author":"Yuzurio","year":"2010","journal-title":"Acta Med Okayama"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bmj.300.6735.1344","article-title":"Hypersensitivity pneumonitis induced by trimethoprim.","volume":"300","author":"Higgins","year":"1990","journal-title":"BMJ"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/pds.4574","article-title":"Trimethoprim: The overlooked component of trimethoprim-sulfamethoxazole idiosyncratic adverse drug reactions.","volume":"27","author":"Goldman","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.chest.2021.09.006","article-title":"ARDS with pneumothorax in a young adult.","volume":"161","author":"Rubin","year":"2022","journal-title":"Chest"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.202009-3421LE","article-title":"Trimethoprim-sulfamethoxazole-associated fulminant respiratory failure in children and young adults.","volume":"203","author":"Miller","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ajpath.2018.01.021","article-title":"A conserved distal lung regenerative pathway in acute lung injury.","volume":"188","author":"Taylor","year":"2018","journal-title":"Am J Pathol"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1164\/rccm.201706-1094LE","article-title":"Delayed alveolar epithelialization: A distinct pathology in diffuse acute lung injury.","volume":"197","author":"Taylor","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41397-022-00266-8","article-title":"HLA-B*07:02 and HLA-C*07:02 are associated with trimethoprim-sulfamethoxazole respiratory failure.","volume":"22","author":"Goldman","year":"2022","journal-title":"Pharmacogenomics J"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"3186328","DOI":"10.1155\/2017\/3186328","article-title":"HLA association with drug-induced adverse reactions.","volume":"2017","author":"Fan","year":"2017","journal-title":"J Immunol Res"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/cts.13062","article-title":"HLA-associated adverse drug reactions - scoping review.","volume":"14","author":"Jeiziner","year":"2021","journal-title":"Clin Transl Sci"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:14:45Z","timestamp":1746191685000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006002","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}